Research indicates quadruplet regimens may be a viable option for this disease.
Sarah Schmidt, PharmD, BCOP
Advertisement
Articles by Sarah Schmidt, PharmD, BCOP
Advertisement
Latest Updated Articles
Assessing Quadruplet vs Triplet Regimens in Up-front Multiple Myeloma TreatmentPublished: October 14th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
2
Pharmacy Policy Updates for October 2025
3
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
4
UConn’s Medical Writing Certificate Program: It’s Just "Write"
5
